Founder of Spero Therapeutics, Inc., Milind S. Deshpande is a businessperson who has been the head of 5 different companies and holds the position of Chairman at Avilar Therapeutics, Inc., President, Chief Executive Officer & Director at Nayan Therapeutics, Inc., Chief Executive Officer & Board Member at Santi Therapeutics, Inc. and Venture Partner at RA Capital Management LP (Private Equity).

He is also on the board of Spero Therapeutics, Inc. (former Director) and Clear Creek Bio, Inc.

In the past Dr. Deshpande held the position of Chief Executive Officer & Director at Achillion Pharmaceuticals, Inc., Associate Director-Lead Discovery at Bristol-Myers Squibb Pharmaceutical Research Institute and Faculty Member at Boston University School of Medicine.

He received a doctorate from The Ohio University.